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Background: Central venous catheter-associated bloodstream infections in children are an increasingly
recognized serious safety problem worldwide, but are often preventable. Central venous catheter bundles have
proved effective to prevent such infections. Successful implementation requires changes in the hospital system as
well as in healthcare professionals’ behaviour. The aim of the study is to evaluate process and outcome of
implementation of a state-of-the-art central venous catheter insertion and maintenance bundle in a large
university children’s hospital.
Methods/design: An interrupted time series design will be used; the study will encompass all children who
need a central venous catheter. New state-of-the-art central venous catheter bundles will be developed. The
Pronovost-model will guide the implementation process. We developed a tailored multifaceted implementation
strategy consisting of reminders, feedback, management support, local opinion leaders, and education. Primary
outcome measure is the number of catheter-associated infections per 1000 line-days. The process outcome is
degree of adherence to use of these central venous catheter bundles is the secondary outcome. A cost-effectiveness
analysis is part of the study. Outcomes will be monitored during three periods: baseline, pre-intervention, and
post-intervention for over 48 months.
Discussion: This model-based implementation strategy will reveal the challenges of implementing a hospital-wide
safety program. This work will add to the body of knowledge in the field of implementation. We postulate that
healthcare workers’ willingness to shift from providing habitual care to state-of-the-art care may reflect the need for
consistent care improvement. Trial registration: Dutch trials registry, trial # 3635.
Trial registration: Dutch trials registry (www.trialregister.nl), trial # 3635
Keywords: Bloodstream infection, Central venous catheter, Prevention, Children’s hospital, Implementation, EducationBackground
Catheter-associated bloodstream infections (CA-BSIs) in
hospitals are a worldwide serious persistent problem. Al-
though often preventable, they are a source of morbidity,
mortality, prolonged hospital stay, and rising costs [1-4].
CA-BSIs notably occur in units where many patients have
central venous catheters (CVC); reported figures range* Correspondence: o.helder@erasmusmc.nl
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reproduction in any medium, provided the orfrom 1.2 to 23.0 CA-BSIs per 1000 line-days in neonatal
intensive care units and from 1.8 to 7.8 CA-BSIs per 1000
line-days in pediatric intensive care units [3-8]. The corre-
sponding figures from a pilot study we performed in 2011
are 11.2 and 7.9. Both unit types admit patients with
compromised immune system and patients undergoing in-
vasive procedures [9]. High incidences in neonatal inten-
sive care units may be due to an immature host defence in
preterm infants [5,10].
Pronovost et al. showed that the introduction of im-
proved CVC insertion techniques helped to bring down
the incidence of CA-BSIs to nearly zero 16 to 18 monthsLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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but the successful outcome encouraged us to improve
the CVC care for all children admitted to our children’s
hospital [11]. A model developed by Pronovost and col-
leagues (“Pronovost-model”) will guide the current study
protocol [12].
There is growing evidence that a combination of inter-
ventions, termed CVC insertion and maintenance bun-
dles, may be effective in preventing CA-BSIs in infants
and children as well [9,13-15]. For example by ensuring
maximum sterile barrier during CVC insertion and ap-
propriate disinfection during intravenous medication
administration. Regrettably, the evidence is limited by
differences in the bundle’s insertion components in the
various studies [13,16].
Each ward in our children’s hospital tends to have its
own habits and protocols with regard to CVC insertion
and maintenance care. These protocols are not all in line
with the available evidence for optimal CVC care. In
addition, the inconsistent policies may confuse patients
and their parents upon transfer to another ward. It would
be best, therefore, to have one hospital-wide, state-of-
the-art CVC insertion and maintenance protocol. Little
has been published, however, on successful implementation
of large scale innovations like this in a children’s hospital,
let alone one guided by the Pronovost-model. The pro-
posed study aims to obtain solid evidence for an effective
implementation method. Furthermore, cost-effectiveness
of the implementation of a CVC bundle has hardly
been addressed, so the question remains whether it pro-
vides good value for money. CA-BSIs are known to be as-
sociated with high costs. A study in a neonatal intensive
care unit in Belgium found that children with CA-BSIs
stayed a mean 24 days longer in hospital at a mean extra
charge of approximately €12,000 (2). In another study from
a pediatric intensive care unit in the USA, the correspond-
ing figures were 9 days and $33,000 (4). Concrete evidence
about the potential of a CVC bundle to lower the costs is
still lacking however. This study may help enlarge the body
of evidence on cost-effectiveness.
The objectives are fourfold: (1) to assess the effects of
hospital-wide implementation of a CVC insertion and
maintenance bundle on the incidence of CA-BSIs per
1000 line-days over 48 months; (2) to assess adherence
to use of the CVC insertion bundle; (3) to assess adher-
ence to use of the maintenance bundle; and (4) to explore
the cost-effectiveness of implementing a CVC insertion
and maintenance protocol.
Scientific hypothesis
We will test the following hypothesis: implementation of
hospital-wide CVC insertion and maintenance bundles
on the guidance of the Pronovost-model promotes proto-
col adherence and reduces the number of CA-BSIs.Methods/design
Study design
An interrupted times series (ITS) analysis will be per-
formed covering a number of three-month periods in
three subsequential phases: pre-intervention, interven-
tion, and post-intervention (Figure 1). The Outbreak
Reports and Intervention studies of Nosocomial infec-
tion (ORION) statement [17] will be applied to guarantee
quality of reporting and the use of appropriate statistical
techniques.
Setting and participants
The setting of this study is the Erasmus MC-Sophia
Children’s Hospital, Rotterdam, the Netherlands. In 2011
it counted 252 beds, 12,403 admissions, and 53,541
patient-days. Distribution over the various wards was as
follows: Neonatal intensive care unit: 27 beds, 775 admis-
sions (8,447 patient-days); pediatric intensive care unit: 34
beds (including 6 beds in high dependency transfer unit),
1504 admissions (10,070 patient-days); medium care units:
96 beds, 4,536 admissions (29,436 patient-days); day-care
ward, 14 beds, 5,588 admissions (5,588 patient-days); and
operation room suite: 8 operation rooms, and 9,207 surger-
ies. All wards except the day-care ward will be participating
in this study.
Implementation model
Implementation will be guided by the Pronovost-model
[12]. The model gives priority to systems operation,
centralised support, a collaborative culture, but also pro-
motes local responsibility. Four stages are distinguished:
(1) Collect evidence on interventions associated with
improved outcomes and select the best feasible ones;
(2) Identify possible barriers to implementation by moni-
toring the current practice and asking stakeholders why
they would not comply with current protocols. On the
other hand, identify intrinsic and extrinsic motivators
that could help implementation; (3) Select process or
outcome measures for adherence to the new protocols.
Monitoring will encourage healthcare workers’ desired
behaviour; (4) All local healthcare workers as much as
possible provide care according to the new protocols.
Striving to achieve an overall high adherence, implemen-
tation will be executed by means of the ‘four Es’: ‘engage’,
‘educate’, ‘execute’, and ‘evaluate’.
Collecting evidence
A state-of-the-art CVC protocol should meet the Cen-
ters for Disease Control and Prevention (CDC) recom-
mendations, be in line with leading studies [3,13], and
be acceptable for key players in all wards. It must ensure
that children who are moved internally always receive
the same CVC care. We will set up a working group and
a steering committee for this purpose. The working group
Figure 1 Interrupted time series study design showing the 48-month timeline of the study, divided into pre-intervention, intervention,
and post-intervention stage.
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port catheters currently used in our children’s hospital.
Evidence for effective measures to prevent infections will
be retrieved from relevant published studies (Table 1)
and assessed on criteria established by the Dutch Institute
for Healthcare Improvement CBO in collaboration with
the Dutch Cochrane library [18]. The most frequently
mentioned measures in these studies are maximum sterile
barrier during insertion procedure, site cleaning with
chlorhexidine, maximum aseptic administration of intra-
venous medication, promotion of hand hygiene, and daily
evaluation of CVC indication [14,19-22]. Based on the
flaws in current practice observed in a pilot study we se-
lected 10 interventions that seemed most appropriate for
our patients. The key features are listed in Table 2. In case
the literature is inconclusive consensus will be reached
through discussion.
The working group will prepare a draft protocol for
approval by the steering group. This will encompass
both the insertion bundle and the maintenance bundle,
each with its sub themes. The insertion bundle consists
of: preparing a CVC insertion cart and providing assist-
ance to the physician or nurse practitioner during the
CVC insertion procedure (e.g. PICC line, umbilical cath-
eter, jugulars/femoralis/subclavia catheter). The main-
tenance bundle consists of: proper daily nursing care,
preparation of intravenous medication, administration of
intravenous medication, blood drawing from a CVC, ad-
ministration of a bacterial-static solution to short bowel
patients, removal procedure, port catheter (e.g. general
port catheter care, administration of medication and re-
moval of the port needle).
Finally, once accepted the protocol will be made easily
accessible at our in-hospital Intranet through keywordsenabling to navigate to all sub themes. In addition we
will write a CVC infection prevention manual with spe-
cial attention to infection prevention in sick children
and the side effects of BSIs. It will also present evidence
from the literature on preventive interventions.
Barriers
We have already explored barriers to successful imple-
mentation of the selected interventions. In five in-depth
semi structured interviews with physicians and nurses
we discussed the key elements of the CVC procedures
that would have to be changed – and at the same time
elicited potential barriers. Nurses as well as physicians
said that applying an air dry time of 30 seconds after dis-
infection of the skin or needless connector was time-
consuming. Physicians in addition doubted the necessity
to use a new needle after failed attempts to insert a CVC
through the skin.
Measuring
The outcome measure is the number of CA-BSIs per
1000 line-days, calculated by dividing the number of
bloodstream infections by the risk-adjusted denomin-
ator 1000 line-days. As a baseline measurement we
prospectively collected data from 1st January 2011 to
1st January 2012. Over that period the number of
CA-BSIs per 1000 line-days was 11.2 at the neonatal
intensive care unit and 7.9 at the pediatric intensive
care unit.
As secondary outcome (process measures) we selected
degree of adherence to safety procedures, e.g. maximum
sterile barrier during the CVC insertion procedure and
adherence to hygienic protocols during intravenous ad-
ministration. Adherence will be documented with the
Table 1 Overview of interventions in and effectiveness of CVC bundles in neonatal intensive care unit and pediatric
intensive care unit settings
Author (year) Setting Design Intervention Reduction of CA-BSI Level of
evidence
Wirtschafter et al. (2010) NICU A Proper CVC insertion, hand hygiene promotion,
closed tubing system, improved hub care
From 4.32 to 3.22 per
1000 line-days
2-
Sannoh et al. (2010) NICU B Hand hygiene promotion, proper hub care using
chloorhexedine with alcohol, glove use promotion,
CVC documentation
From 23 to 12 per
1000 line-days*
2++
Bizzarro et al. (2010) NICU B Proper CVC placement, promotion of hand hygiene,
daily evaluation CVC need, infection surveillance,
dressing replaced on indication
From 8.40 to 1.28 cases
per 1000 line-days*
2+
Andersen et al. (2005) NICU# B Hand hygiene promotion, maximum barrier during
CVC insertion, daily evaluation need for CVC removal
From 21% to 9% (P=0.05,
confidence intervals
0.19–1.0)*
2+
Costello et al. (2008) PICU C Hand hygiene promotion, daily evaluation need
for CVC removal, CVC insertion kid
From 7.8 to 4.7 and to
2.3 per 1000 line-days
2-
McKee et al. (2008) PICU D Proper insertion and nursing care, empower nurses
to stop the insertion procedure if guidelines were
not followed, using a checklist to ensure adherence
to the guidelines, providing weekly performance
feedback, promotion of hand hygiene, chlorhexedine
skin preparation,
From 5.2 to 3.0 per
1000 line-days*
2+
Jeffries et al. (2009) PICU E Maximum sterile barrier during CVC insertion,
hand hygiene promotion, apply transparent dressing,
prepare skin with anti and/ or detergent chlorhexidine
gluconate 2%,
From 6.3 to 4.3 per
1000 line-days*
2+
Miller et al. (2010) PICU F Disinfect catheter site using chlorhexedine,
maximum barrier, full barrier during pre-packages
of the insertion tray, daily assess CVC need, gauze
change every 2 days
From 5.4 to 3.1 per
1000 line-days*
2+
Wheeler et al. (2011) Children’s
hospital-wide
D Full barrier precautions, chlorhexedine skin
preparation with 2 minutes scrub and 1 minute
air dry, use of insertion checklist, staff empowerment
to stop the insertion procedure, daily assess CVC
need, promotion of hand hygiene,
chlorhexidine-impregnated sponge placed at insertion
site, glove use for all CVC manipulations, change
dressing every 7 day or on indication earlier, replace
tubing sets no more than 72 hour, cap change
every 7 day
From 3 to <1 per
1000 line-days*
2+
Chuengchitraks et al. (2010) PICU G Promotion of hand hygiene, maximal barrier
precautions, provide skin antiseptic, optimal
catheter site selection
From 2.6 to 2.4 per
1000 line-days
2-
Design: A: multi center prospective pre-test posttest study; B: single center prospective pretest and posttest study; C: single center retrospective pretest and
prospective posttest group, interrupted time series design; D: single center retrospective pretest and prospective posttest group, time series design; E: multicenter,
prospective pretest and posttest group, time series; F: multicenter retrospective pretest and posttest group, interrupted time series; G: single center cohort study;
1++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias; 1+ Well-conducted meta-analyses, systematic reviews of RCTs, or
RCTs with a low risk of bias; 1- Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias; 2++ High-quality systematic reviews of case–control or
cohort studies, or high-quality case–control or cohort studies with a very low risk of confounding, bias, or chance and a high probability that the relationship is
causal; 2+ Well-conducted case–control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is causal;
2- Case–control or cohort studies with a high risk of confounding, bias or chance, and a significant probability that the relationship is not causal; 3 Non-analytic studies; for
example, case reports, case series; 4 Expert opinion.
CVC central venous catheter, BSI bloodstream infection, NICU neonatal intensive care unit, PICU pediatric critical care unit.
#Premature born infants with birth weight < 1500 grams; and *indicate significant reduction of bloodstream infections per 1000 line-days.
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ance related to the insertion procedure will be measured
with two tools: use of the time out procedure that is
linked with the CVC insertion protocol (Additional file 1:
Table S1) and a questionnaire daily popping up in the
patient’s electronic record informing after signs ofinfection at insertion site as well as the need of having the
CVC in place.
Implementation strategies
Engage. We will inform all stakeholders and senior man-
agement staff about the current high number of CA-
Table 2 Major components of CVC insertion bundle and maintenance bundle in The Erasmus MC-Sophia
Children’s Hospital
Insertion bundle Components
Strict hand hygiene according to “my 5 moments”#
Full sterile barrier Hygienic precaution training for all healthcare workers who insert CVCs
Sterile gown, mask, hat, double sterile gloves worn by the healthcare
worker who inserts the CVC
Use of pre-packaged CVC insertion kit
Sterile drape covering the patient for least 80%
Physical barrier between the environment and the child, insertion cart,
and healthcare worker who inserts the CVC
Insertion site cleaned with alcohol 70% with chlorhexidine 0.5%
(chlorhexedine 0.2% in water for infants < 26 weeks gestational age)
Use of a timer displayed at the bedside’s screen to secure an air dry
time of at least 30 seconds
Use a new needle after each attempt to insert a CVC through the
intact skin
Chlorhexedine impregnated sponge attached at insertion site
(not in infants < 40 weeks gestational age)
Maintenance bundle
Strict hand hygiene according to “my 5 moments”#
Hand hygiene Hand washing when entering the unit, after using the bathroom,
and when hands are visually soiled
Hand disinfection during all other occasions
Using gloves when risk of contact with body fluids
Catheter site care Daily inspection of insertion site (e.g. redness, collection of fluids, swelling)
Change transparent semi permeable dressing on indication only
(e.g. loosened, collection of fluids)
Hub care Disinfection of the hub with alcohol 70% and air dry for at least
30 seconds
Use of a timer displayed at the bedside’s screen to secure an air dry
time of at least 30 seconds
Tubing care Replace continuous tubing sets every 96 hours, unless visually soiled
of contaminated
Daily replace tube containing lipids, medication, blood or blood products
Remove intermitted administration sets directly after administration
of medication
Daily question whether CVC still needed
#My 5 moments adopted from the CDC [23].
CVC central venous catheter.
Helder et al. BMC Health Services Research 2013, 13:417 Page 5 of 11
http://www.biomedcentral.com/1472-6963/13/417BSIs per 1000 line-days and the need to reduce this
number, and address the undesirability of having differ-
ent CVC protocols in place – implying we need to im-
plement general preventive measures hospital-wide.
Representative stakeholders from all wards will be in-
vited to join the steering committee. Final approval of
the CVC protocol by the steering committee is required
and the members will support implementation in their
respective wards and operation room suite.
Table 5 provides an overview of proposed imple-
mentation strategies. Strategies for the disseminationof knowledge are based on the Pronovost-model and
others [12,24,25].
Engage & educate. To improve engagement and educa-
tion level we will organise a hospital-wide theme week
dedicated to CA-BSIs reduction. Events are aimed at edu-
cating all staff involved on the new CVC protocol and
CVC infection prevention manual and persuading them to
change their usual care and comply with the new protocol.
Two weeks prior, posters announcing the program will be
spread, provided with supportive one-liners from senior
management and senior clinical leaders including their
Table 3 Process indicators CVC insertion monitoring form
Process indicator Satisfied
1 Skin cleaned with alcohol 70% with chlorhexidine 0.2%; or chlorhexidine 0.2% in water in infants with a gestational age < 26 weeks Yes O No O
2 Air dry of at least 30 seconds after skin preparation prior to guide-wire insertion Yes O No O
3 New needle used after each attempt to insert a CVC through the intact skin Yes O No O
4 Sterile drape covering the patient for least 80% Yes O No O
5 The provider inserting the CVC used maximum sterile barrier e.g. sterile gown, double sterile gloves, mask, and hat Yes O No O
6 Optimal insertion site was selected or another site was argued for Yes O No O
7 Echo use during insertion of jugularis and subclavia catheter Yes O No O
8 Chlorhexidine impregnated sponge used in infants < 40 weeks gestational age Yes O No O
CVC central venous catheter.
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protocol will act as role models for more junior colleagues.
During the CVC week, flyers presenting the key players’
one-liners and the on-liner messages will be used as
screen savers throughout the children’s hospital [27].
A tentative schedule is the following:
Monday; flyer distribution, informative mini-symposium,
marking of ten potential dirty surfaces at each ward,
attaching a sticker on them and culturing the surfaces.
Tuesday; nurses visit bacterial laboratory and the new
guidelines are discussed;
Wednesday; physicians and nurse practitioners receive
clinical instructions; tables in the staff restaurant are
decked out with placemats asking questions on appro-
priate CVC care; lecture on reasons for non-adherence
to hand hygiene protocols.
Thursday; clinical instructions and lecture to promote
high adherence to documenting CVC data in the patient
data management system.
Friday, theme week wrap-up with musical act during
lunch-time in the staff restaurant and a closing ceremony.Table 4 Process indicators CVC nursing care monitoring form
Process indicator
1 Appropriate hand hygiene prior to preparation of intravenous medica
2 Disinfection of the cap or ampoule’s surface using alcohol 70%
3 Applying 30 seconds air drying time after disinfection ampoule’s surfa
4 Disinfection of connector with alcohol 70%#
5 Or disinfection of the stop cock in case intravenous medication is adm
6 Applying 30 seconds air dry time for the stop cock of connector
7 Daily question whether the CVC is still needed in PDMS
8 Daily check of the insertion place for inflammation
9 Aspirated blood from the CVC will not be returned to the patient
10 The blue side of the Biopatch is visible
CVC central venous catheter, PDMS patient data management system.
#select one depending on the mode of administration.Detailed information concerning the infection preven-
tion week is supplemented at Additional file 2.
For educational purposes we will use several types of
reminders, such as screen savers; stickers attached on dis-
infection solution bottles displaying the message: “apply
30 seconds air dry time”; infection prevention messages
printed on toilet paper. Furthermore, if a CVC is in situ, a
questionnaire will daily pop up in the patient’s record in
the electronic patient data management system. The ques-
tionnaire addresses the following items: “Is the transparent
dressing in good order?”; “Is there any redness near the
insertion place?”; and “Is the CVC still needed?”. The
response categories will be collected at nominal level e.g.
yes or no.
Evaluate. Quarterly, the primary and secondary out-
comes will be measured to evaluate whether the inter-
vention is successful and to identify possible flaws. The
information obtained may serve as input for additional
improvements. Data will be compared to the baseline
measurement data and data collected in the previous
period, if applicable, by interrupted time series analysis.Satisfied
tion Yes O No O
Yes O No O
ce Yes O No O
Yes O No O
inistered using an extension-line applying alcohol 70%# Yes O No O
Yes O No O
Yes O No O
Yes O No O
Yes O No O
Yes O No O
Table 5 Selected implementation strategies
Intervention types Components
Education program,
theme week
Multidisciplinary seminar
Workshop for physicians
Instruction for nurses
Instruction on hygienic insertion and
maintenance
Reminders Leaflets
Screen savers
Daily questionnaire CVC need, pop-up in
electronic patient management system
Sticker attached at disinfection solution:
apply 30 seconds air dry time
Feedback (quarterly) Reporting incidence of CA-BSI
Reporting adherence to insertion bundle
Reporting adherence to maintenance bundle
Engagement of the
managing staff
One-liners combined with picture
Awareness Time out procedure, and staff empowerment
to stop in case of protocol violation
Daily goal sheet
Procedures Revised protocols
CVC infection preventions manual.
Timers
30 seconds air dry timer displayed on
bedside screen
CA-BSI catheter-associated bloodstream infection, CVC central venous catheter.
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dren’s hospital. Furthermore, findings on ward level will
be presented to the management of the relevant ward.
For steering purposes we will make use of insightful
graphs and tables. Successful outcomes may be an incen-
tive to continue on the road we have taken; negative out-
comes may be an incentive to increase efforts.
Endure and extend. Pronovost and colleagues later
added this idem to their model [12]. We postulate that the
daily questioning on the need to have the CVC in place, as
sketched above, will create awareness of safety precautions.
Furthermore, we presume that sharing of the quarterly per-
formance outcomes will improve perceptions of safe pa-
tient care. Finally, encouraging open discussion about
possible procedure flaws and potential improvements will
benefit the CVC process at large [25].
Primary outcome
The primary outcome will be the laboratory confirmed
number of CA-BSIs per 1000 line-days, following the
CDC definition: (1) one or more positive blood culture(s)
(not skin flora) and no other infection source; or (2) onepositive blood culture and clinical signs and no other infec-
tion source [28]. The diagnosis will be made jointly by a
member of the research team (OH, CvdS) and an infection
control practitioner. Discrepancies between these persons
will be resolved through discussion until consensus is
reached; or will be solved by an independent physician
using the institutional microbiological database and the pa-
tient file. The CDC defines CA-BSI as a primary BSI if a
CVC was in place 48 hours before the development of the
BSI and if it is not bloodstream related to an infection at
another site [29]. A CVC in situ is defined as a catheter
introduced into a vein that terminates close to the heart
or into one of the great vessels, and which is used for in-
fusion, blood sampling or hemodynamic monitoring. Data
concerning the number of line-days will be abstracted
from the digital patient data management systems. It may
be an umbilical venous catheter, a percutaneous CVC, a
tunneled catheter, a port, or a peripherally inserted cen-
tral catheter (PICC) [30].
Secondary outcomes
Rate of adherence to the CVC insertion bundle and rate
of adherence to the maintenance bundle will serve as
secondary outcomes.
The attending nurse will assess adherence to the CVC
insertion bundle during the insertion procedure (Table 3).
To this aim we designed a digital tab with drop-down
menu for the two different patient data management sys-
tems. The time out procedure prior to the CVC insertion
is predominantly added for creating safety awareness dur-
ing insertion (Additional file 1: Table S1). During the in-
sertion procedure all involved healthcare workers are
encouraged to make comments and to stop the proced-
ure in case of violation of insertion bundle. Intravenous
medication preparation and administration items will
serve to measure adherence to the CVC maintenance
bundle (Table 4). Purpose-trained nurses will randomly
assess these items during planned daily care.
Economic costs and benefits
Additionally, the cost-effectiveness of the implementa-
tion of the CVC bundle will serve as a secondary outcome
measure, to be established through cost-effectiveness
analysis. Taking a health care perspective, the cost-
effectiveness analysis will make a comparison between
the pre-intervention period (‘usual care’) and the post-
intervention period regarding both the total costs and
the number of CA-BSIs per 1,000 line-days.
Among the costs included will be the direct medical
costs relating to CA-BSIs. These costs will be calculated
by multiplying resource utilization with a unit cost price.
As much as possible, real economic cost prices will be
used rather than charges. Cost prices will be calculated
according to established methods [31]. The time
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until discharge.
Any possible savings on the costs of medical care need
to be balanced against the costs of implementing the
CVC bundle. All costs related to the implementation
process will be taken into account. This implies that the
study will take account of the costs for the implementa-
tion strategies (Table 5), as well as the changes in the
care implicit to the implementation of the CVC bundle
(Table 2) insofar as they result in additional costs
compared to usual care. To arrive at total costs, we will
include both personnel costs, material costs, and over-
head costs.
Data collection
Four nurses trained in observation will unobtrusively
observe staff when they apply the insertion and main-
tenance bundles. Observation will be guided by a self-
designed structured case report form. The staff will be
unaware of the reason for the observations; they are
already frequently observed for training or research pur-
poses. Data collection will be at random moments seven
days a week and 24 hours a day. Sealed envelopes will be
used to ensure an equal allocation of these two-hour ob-
servations over the wards and observation times during
the day. Data on sex, (birth) weight, and age of the pa-
tients involved will be retrieved from the patient data
management systems (Additional file 3: Table S2). Dis-
ease severity of infants admitted to the neonatal inten-
sive care unit will be documented by the Clinical risk
index for babies (CRIB) score [32]; that of children ad-
mitted to the pediatric intensive care unit by the
Pediatric Risk of Mortality III score (PRISM III) [33] or
Pediatric Index of Mortality (PIM) score [34]; that of
children admitted to the oncology department by the
Lansky score (children ≤ 9 year) [35] or Karnofsky score
(children > 10 year) [35]. There is no suitable disease sever-
ity score for patients admitted to the medium care ward,
due to the diversity of diseases.
Statistical analysis
Data will be expressed as median and interquartile range
(IQR), unless indicated otherwise. The baseline data
showed that 69 children developed a CA-BSI. The effect
of the intervention on rate reduction will be determined
with a segmented loglinear regression analysis of inter-
rupted time series, using a pre-intervention, interven-
tion, and post-intervention segment. The slope or trend
of the segments indicates the rate of change in time. An
abrupt change at the time of the implementation indi-
cates an immediate effect. Introducing slopes (percentual
changes in time in infection rate before and after the
implementation) corrects for unassociated background
trends. A change in slope after the introduction of theintervention may identify a gradual effect of the imple-
mentation [17,36]. We aggregated CA-BSIs per 1,000 line-
days over 3-month periods. This figure will also be used in
the cost-effectiveness analysis, which is concerned with
the differences in outcome and total costs between the
pre-intervention and the post-intervention period. Cost-
effectiveness is assessed through the calculation of an
incremental cost-effectiveness ratio (ICER). The ICER is
calculated as the incremental costs per case of CA-BSI per
1,000 line-days avoided. The cost-effectiveness analysis
will include a sensitivity analysis to assess how sensitive
the results are to any assumptions made.
Sample size
For the power analysis we made some simplifying as-
sumptions: only pre- and post-intervention periods are
compared and instead of comparing slopes we compare
levels of infection rate. Under these circumstances a
length of 1.9 years before and after intervention (leading
to an assumed number of 141 cases before) is enough to
detect a drop in rate to 70%. When we apply loglinear re-
gression analysis with Poisson error distribution corrected
for number of days at risk we find that that two times 1.9
years leads to a power of 80%.
The baseline rates of adherence to the insertion and
maintenance bundles are estimated at 60% and 20%, re-
spectively; the post intervention rates aimed at are 100%
and 45%, respectively. Sample size calculation indicated
that each sequential period requires 15 insertion obser-
vations and 45 maintenance observations to detect a
relative difference of 37% and 125% alpha of 0.05 and a
1-beta of 0.8.
Ethical aspects
The Erasmus MC Institutional Review Board approved
this study (MEC-2012-375).
Discussion
The implementation strategy encompasses a multifa-
ceted program tailor made for this specific hospital and
ready for use. We hypothesize that implementation of
this program will result in fewer CA-BSIs and improved
adherence to CVC bundles [5,22,24,37]. Tailored imple-
mentation strategies – i.e. based on content analysis of
barriers and facilitators – seem to be more effective than
non-tailored strategies [38,39]. The Pronovost-model ef-
fectively helped to design strategies from the first to the
last phase.
Various strategies will be employed. First, education by
means of a mini-symposium, workshops, presentations,
and so on. Second, improving staff intrinsic motivation,
e.g. by audit, feedback, and reminders. Third, organisa-
tional change: preparing on single protocol for all patients.
Fourth, use of ICT: e.g. a timer on the computer screen at
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access to guidelines and the CVC infection prevention
manual, use of screen savers, and daily reminder informing
whether the CVC is still needed. Fifth, feedback: quarterly
reporting of the CA-BSI incidence and the rates of adher-
ence to the insertion and maintenance bundles. Sixth,
awareness: time out procedure and daily goal sheet. Sev-
enth, engagement of the managing staff: showing their
commitment to the aim.
The Pronovost-model recommends enlisting all local
stakeholders involved in patient care and discussing with
them potential barriers and facilitators to adherence to
the developed protocol. The Pronovost-model does not
provide for eliciting support from senior management of
the hospital. Nevertheless, they will be asked to demon-
strate their commitment and assume ownership of the
general aim to reduce CA-BSIs hospital-wide [25]. We
will explicitly designate senior management as ambassa-
dors of the goals [40] by publishing their one-liners and
portrait pictures. These ambassadors should convince all
healthcare workers that safer CVC care is an important
goal and make clear they support the campaign. The se-
nior management is officially accountable for patient
safety and even may act as role models.
Use of opinion leaders will be added to the implemen-
tation strategy. Clinical and senior management need to
show their vision and clearly dissimilate this particular
aspect of safety culture. Senior management of effective
infection prevention programs dissimilated their success
as improved clinical excellence and inspired their staff
[26]. Furthermore, senior management will help resolve
organizational and financial barriers and practically sup-
port initiatives [25,26].
The Pronovost-model describes the implementation
process in broad terms; development of a fitting protocol
or work-instruction is not included [12]. We will there-
fore add a comprehensive description of how to develop
a work-instruction. Evidence from recently published
studies should support the newly developed protocol
and providing evidence will perfectly fit into phase 1 of
the Pronovost-model; building evidence in favour for the
chosen intervention.
Feedback is a widely used, powerful measure to in-
crease adherence to infection prevention measures
such as good hand hygiene [24,41]. However, once
feedback is stopped any unwanted behaviour could
come up again [24,42]. On the other hand, providing
continuous feedback is time consuming and therefore not
realistic. Feedback should be used firstly to alter initial un-
wanted behaviour and this should ideally move into desired
behaviour as an intrinsic driven and well-conditioned
behaviour.
Education is often used to support behavioural change,
especially if flaws in knowledge are observed [5,40,43]. Acomplicating factor is that level of knowledge varies
among healthcare workers categories and within cat-
egories. This should be borne in mind when developing
a hospital-wide education program. Physicians may tend
to appreciate knowledge more than do nurses, and
evidence-based education could be very useful to promote
physicians’ desired behaviour [44]. On the other hand, a
wash-out effect is often observed [45,46]. This means that
knowledge previously received may recede to the back-
ground. Ideas on what is effective in infection prevention
are developing over time, so regular updates are essential.
In addition, repetition of education programs is necessary
in a teaching hospital like ours; many healthcare workers
are in training and leave the hospital after having com-
pleted their education program.
The Pronovost-model is merely medical oriented. The
main point of departure from the model is knowledge
transfer, which fits into physicians’ learning style [44].
Goossens et al. found that strong scientific evidence was
the strongest determinant of physicians’ behaviour [44].
However, regarding our goal, a clear healthcare team
angle seems to be more appropriate for a broad dissimila-
tion of improved hygienic behaviour among all members
of the multidisciplinary team. Nurses have a more active
learning style, and the strongest determinant of knowledge
acquisition was found the be the fact whether the subject
was ‘interesting […] or not’ [44]. This phenomenon affects
whether a new procedure is potentially beneficial for pa-
tients or gets embedded in the daily care.
We postulate that the proposed study has methodo-
logical strength because it is guided by a validated imple-
mentation model that has been translated into a hands-on
program and is described in detail for implementation
hospital-wide. Furthermore, regularly reporting the out-
comes is in line with the ORION statement promoting
transparent reporting on intervention studies aimed to
reduce nosocomial infections. ORION recommended
interrupted time series as preferable method for analysis
showing the change in results over time.
We anticipate several challenges in this study. (1) Effect-
iveness of interventions is preferably evaluated by random-
isation into an intervention and control group. However,
this method is inappropriate for our aim to implement an
intervention hospital-wide, and the interrupted time series
design is the second best solution and in line with the
ORION guidelines (2). The CVC bundle is adapted and
tailor made for our hospital. Although this results in less
generalizability, this naturalistic approach could help de-
velop practical implementation strategies for other hospi-
tals or other interventions. (3) The effective ingredients of
the bundle are still unclear. However, as some interven-
tions have been shown to be effective it would be unethical
to test all separate interventions. (4) To control for con-
founders is a challenge due to the different safety climates
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ship we will try to show the benefits of a univocal approach
towards infants’ CVC care.
Nevertheless, this detailed implementation strategy of
the CVC bundle has a potential to effectively modify
healthcare workers behaviour and reduce the number of
CA-BSIs hospital-wide.
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CVC insertion.
Additional file 2: Detailed program of the CVC bloodstream
infection reduction theme week.
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Abbreviations
CA-BSI: Catheter-associated bloodstream infections; CDC: Centers for disease
control and prevention; CVC: Central venous catheter; IQR: Inter quartile
range; IV: Intra venous; ITS: Interrupted time series.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
This manuscript was prepared by the authors. OH, EI and CvdS were responsible
for the research question, OH and EI designed the study. OH and EI wrote the
initial draft of the manuscript and all authors contributed to redrafting. CL is the
statistician who offered advice on the power calculation, the sample size
considerations and advice on the statistical methods. MP is a health scientist and
provided economic evaluation advice. DT and RW are the general supervisors of
the study and were involved in revising the manuscript. All authors read and
approved the final version of the manuscript.
Acknowledgment
Jan Dekker is thanked for his contribution to identify potential barriers.
Marian de Jong and Willemijn Corpeleijn are thanked for collection baseline
data concerning bloodstream infections per 1000 CVC days. Oetze Vlasblom
is thanked for providing support for this project at management and ICT
level. We thank Ko Hagoort for text editing.
Source of funding
EI was supported by an “implementation research fellowship” grant of The
Netherlands Organization for Health Research and Development (ZonMw),
ZonMw grant: 170996007.
Author details
1Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia
Children’s Hospital, Erasmus University Medical Centre, Rotterdam,
The Netherlands. 2Department of Pediatric Surgery, Erasmus MC - Sophia
Children’s Hospital, Erasmus University Medical Centre, Rotterdam, The
Netherlands. 3Department of Public Health, Erasmus University Medical
Centre, Rotterdam, The Netherlands. 4Institute for Medical Technology
Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The
Netherlands.
Received: 19 October 2012 Accepted: 18 September 2013
Published: 14 October 2013
References
1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA,
Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB,
Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK: Late-onset
sepsis in very low birth weight neonates: the experience of the NICHD
neonatal research network. Pediatrics 2002, 110(2 Pt 1):285–291.2. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ: Additional hospital stay
and charges due to hospital-acquired infections in a neonatal intensive
care unit. J Hosp Infect 2001, 47(3):223–229.
3. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC:
Systematic intervention to reduce central line-associated bloodstream
infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008,
121(5):915–923.
4. Nowak JE, Brilli RJ, Lake MR, Sparling KW, Butcher J, Schulte M, Wheeler DS:
Reducing catheter-associated bloodstream infections in the pediatric
intensive care unit: business case for quality improvement. Pediatr Crit
Care Med 2010, 11(5):579–587.
5. Helder OK, Brug J, Looman CW, Van Goudoever JB, Kornelisse RF: The
impact of an education program on hand hygiene compliance and
nosocomial infection incidence in an urban neonatal intensive care unit:
an intervention study with before and after comparison. Int J Nurs Stud
2010, 47(10):1245–1252.
6. Leboucher B, Leblanc M, Berlie I, Savagner C, Lemarie C, Le Bouedec S:
Effectiveness of an informative report on the prevention of nosocomial
bloodstream infections in a neonatal intensive care unit. Arch Pediatr
2006, 13(5):436–441.
7. Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B: A multimodal
approach to central venous catheter hub care can decrease catheter-
related bloodstream infection. Am J Infect Control 2010, 38(6):424–429.
8. Lam BC, Lee J, Lau YL: Hand hygiene practices in a neonatal intensive
care unit: a multimodal intervention and impact on nosocomial
infection. Pediatrics 2004, 114(5):e565–571.
9. Jeffries HE, Mason W, Brewer M, Oakes KL, Munoz EI, Gornick W, Flowers LD,
Mullen JE, Gilliam CH, Fustar S, Thurm CM, Logsdon T, Jarvis WR: Prevention
of central venous catheter-associated bloodstream infections in pediatric
intensive care units: a performance improvement collaborative. Infect
Control Hosp Epidemiol 2009, 30(7):645–651.
10. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B,
Higgins RD: Neurodevelopmental and growth impairment among
extremely low-birth-weight infants with neonatal infection. JAMA 2004,
292(19):2357–2365.
11. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S,
Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C: An
intervention to decrease catheter-related bloodstream infections in the
ICU. N Eng J Med 2006, 355(26):2725–2732.
12. Pronovost PJ, Berenholtz SM, Needham DM: Translating evidence into
practice: a model for large scale knowledge translation. BMJ 2008,
337:a1714.
13. Bizzarro MJ, Sabo B, Noonan M, Bonfiglio MP, Northrup V, Diefenbach K:
Central venous catheter initiative C: a quality improvement initiative to
reduce central line-associated bloodstream infections in a neonatal
intensive care unit. Infect Control Hosp Epidemiol 2010, 31(3):241–248.
14. Miller MR, Griswold M, Harris JM 2nd, Yenokyan G, Huskins WC, Moss M,
Rice TB, Ridling D, Campbell D, Margolis P, Muething S, Brilli RJ: Decreasing
PICU catheter-associated bloodstream infections: NACHRI's quality
transformation efforts. Pediatrics 2010, 125(2):206–213.
15. Helder O, van den Hoogen A, De Boer C, Van Goudoever J, Verboon-Maciolek M,
Kornelisse R: Effectiveness of non-pharmacological interventions for the
prevention of bloodstream infections in infants admitted to a neonatal
intensive care unit: a systematic review. Int J Nur Stud 2013, 50(6):819–831.
16. Aly H, Herson V, Duncan A, Herr J, Bender J, Patel K, El-Mohandes AAE: Is
bloodstream infection preventable among premature infants? A tale of
two cities. Pediatrics 2005, 115(6):1513–1518.
17. Cooper BS, Cookson BD, Davey PG, Stone SP: Introducing the ORION
statement, a CONSORT equivalent for infection control studies. J Hosp
Infect 2007, 65(Suppl 2):85–87.
18. CBO: Evidence-based Guideline development. Manual for working group
members of Dutch institute for healthcare improvement (Kwaliteitsinstituut
voor de Gezondheidszorg). In Kwaliteitsinstituut voor de Gezondheidszorg
CBO. Utrecht: CBO; 2007:1–76.
19. Andersen C, Hart J, Vemgal P, Harrison C: Prospective evaluation of a
multi-factorial prevention strategy on the impact of nosocomial infection in
very-low-birthweight infants. J Hosp Infect 2005, 61(2):162–167.
20. McKee C, Berkowitz I, Cosgrove SE, Bradley K, Beers C, Perl TM, Winner L,
Pronovost PJ, Miller MR: Reduction of catheter-associated bloodstream
infections in pediatric patients: experimentation and reality. Pediatr Crit
Care Med 2008, 9(1):40–46.
Helder et al. BMC Health Services Research 2013, 13:417 Page 11 of 11
http://www.biomedcentral.com/1472-6963/13/41721. Chuengchitraks S, Sirithangkul S, Staworn D, Laohapand C: Impact of new
practice guideline to prevent catheter-related blood stream infection
(CRBSI): experience at the pediatric intensive care unit of
Phramongkutklao Hospital. J Med Assoc Thai 2010, 93(Suppl 6):S79–83.
22. Wheeler DS, Giaccone MJ, Hutchinson N, Haygood M, Bondurant P,
Demmel K, Kotagal UR, Connelly B, Corcoran MS, Line K, Rich K,
Schoettkinger PJ, Brilli RJ: A hospital-wide quality-improvement
collaborative to reduce catheter-associated bloodstream infections.
Pediatrics 2011, 128(4):e1004–1007. e995-e1004; quiz.
23. Sax H, Allegranzi B, Chraiti MN, Boyce J, Larson E, Pittet D: The World
Health Organization hand hygiene observation method. Am J Infect
Control 2009, 37(10):827–834.
24. Grol R, Grimshaw J: From best evidence to best practice: effective
implementation of change in patients' care. Lancet 2003,
362(9391):1225–1230.
25. Zingg W, Walder B, Pittet D: Prevention of catheter-related infection:
toward zero risk? Curr Opin Infect Dis 2011, 24(4):377–384.
26. Saint S, Kowalski CP, Banaszak-Holl J, Forman J, Damschroder L, Krein SL:
The importance of leadership in preventing healthcare-associated
infection: results of a multisite qualitative study. Infect Control Hosp
Epidemiol 2010, 31(9):901–907.
27. Helder OK, Weggelaar AM, Waarsenburg DC, Looman CW, Van Goudoever JB,
Brug J, Kornelisse RF: Computer screen saver hand hygiene information
curbs a negative trend in hand hygiene behavior. Am J Infect Control 2012,
40(10):951–954.
28. Edwards JR, Peterson KD, Andrus ML, Tolson JS, Goulding JS, Dudeck MA,
Mincey RB, Pollock DA, Horan TC, Facilities N: National Healthcare Safety
Network (NHSN) Report, data summary for 2006, issued June 2007. Am J
Infect Control 2007, 35(5):290–301.
29. Naomi P, O'Grady MA, Lillian A, Burns E, Patchen D, Jeffery G, Heard SO,
Lipsett PA, Henry M, Mermel LA, Pearson ML, Raad II, Adrienne R, Mark E:
Rupp, Sanjay Saint, and the Healthcare Infection Control Practices
Advisory Committee (HICPAC). Guidelines for the prevention of intravascular
catheter-related infections. Clin Infect Dis 2011, 52(9):e162–193.
30. Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, Seid M,
Byczkowski TL, Huber TP, Milstein JM, Bowles SM, Fichera S, Kloman S: A
statewide quality improvement collaborative to reduce neonatal central
line-associated blood stream infections. J Perinatol 2010, 30(3):170–181.
31. Hakkaart-van Roijen LTS, Tan SS, Bouwmans CAM: Manual for costing
research. Methods and guideline prices for economic evaluations of health care
interventions (updated edition [in Dutch]. Diemen: Health Care Insurance
Board; 2010:1–127.
32. The CRIB: (clinical risk index for babies) score: a tool for assessing initial
neonatal risk and comparing performance of neonatal intensive care
units. The International Neonatal Network. Lancet 1993, 342(8865):193–198.
33. Pollack MM, Patel KM, Ruttimann UE: PRISM III: an updated Pediatric Risk
of Mortality score. Crit Care Med 1996, 24(5):743–752.
34. Shann F, Pearson G, Slater A, Wilkinson K: Paediatric index of mortality
(PIM): a mortality prediction model for children in intensive care.
Intensive Care Med 1997, 23(2):201–207.
35. Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS,
Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS,
Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP,
Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horrowitz MM, Pavletic SZ:
Risk factors associated with increased nonrelapse mortality and with poor
overall survival in children with chronic graft-versus-host disease. Blood 2011,
118(16):4472–4479.
36. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D: Segmented regression
analysis of interrupted time series studies in medication use research.
J Clin Pharm Ther 2002, 27(4):299–309.
37. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P,
Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C:
Effectiveness and efficiency of guideline dissemination and
implementation strategies. Health Technol Assess 2004, 8(6):1–72. iii-iv.
38. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S,
Robertson N: Tailored interventions to overcome identified barriers to
change: effects on professional practice and health care outcomes.
Cochrane Database Syst Rev 2010, 3, CD005470.
39. Bosch M, van der Weijden T, Wensing M, Grol R: Tailoring quality
improvement interventions to identified barriers: a multiple case
analysis. J Eval Clin Pract 2007, 13(2):161–168.40. Huis A, Schoonhoven L, Grol R, Borm G, Adang E, Hulscher M, Van Achterberg T:
Helping hands: A cluster randomised trial to evaluate the effectiveness of
two different strategies for promoting hand hygiene in hospital nurses.
Implement Sci 2011, 6:101.
41. Boaz A, Baeza J: Fraser A, the European implementation score
collaborative G: effective implementation of research into practice: an
overview of systematic reviews of the health literature. BMC Res Notes
2011, 4(1):212.
42. Naikoba S, Hayward A: The effectiveness of interventions aimed at
increasing handwashing in healthcare workers - a systematic review.
J Hosp Infect 2001, 47(3):173–180.
43. Erasmus V, Huis A, Oenema A, Van Empelen P, Boog MC, Van Beeck EH,
Polinder S, Steyerberg EW, Richardus JH, Vos MC, Van Beeck EF: The
ACCOMPLISH study. A cluster randomised trial on the cost-effectiveness
of a multicomponent intervention to improve hand hygiene compliance
and reduce healthcare associated infections. BMC Public Health 2011,
11:721.
44. Goossens A, Bossuyt PM, De Haan RJ: Physicians and nurses focus on
different aspects of guidelines when deciding whether to adopt them:
an application of conjoint analysis. Med Decis Making 2008, 28(1):138–145.
45. Helder OK, Latour JM: Undergraduate nurse students' education in
infection prevention: is it effective to change the attitude and
compliance with hand hygiene? Nurs Crit Care 2010, 15(1):39–40.
46. Salemi C, Canola MT, Eck EK: Hand washing and physicians: how to get
them together. Infect Control Hosp Epidemiol 2002, 23(1):32–35.
doi:10.1186/1472-6963-13-417
Cite this article as: Helder et al.: Implementation of a children’s hospital-
wide central venous catheter insertion and maintenance bundle. BMC
Health Services Research 2013 13:417.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
